A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
出版年份 2021 全文链接
标题
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
作者
关键词
-
出版物
Genes
Volume 12, Issue 8, Pages 1206
出版商
MDPI AG
发表日期
2021-08-04
DOI
10.3390/genes12081206
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment
- (2021) Yueyuan Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review
- (2021) Noora Karim Ahangar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation
- (2021) Narges Dastmalchi et al. MOLECULAR BIOLOGY REPORTS
- Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
- (2021) Fatemeh Oroojalian et al. Small
- miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis
- (2021) Behzad Mansoori et al. Genes
- From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
- (2021) Mahdi Abdoli Shadbad et al. Frontiers in Immunology
- An Updated Review of the Cross-talk between MicroRNAs and Epigenetic Factors in Cancers
- (2021) Narges Dastmalchi et al. CURRENT MEDICINAL CHEMISTRY
- MiRNA-138–5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis
- (2021) Mina Rasoolnezhad et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy
- (2021) Afshin Derakhshani et al. MOLECULES
- Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
- (2021) Amal Qattan et al. Genes
- PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines
- (2021) Parisa Lotfinejad et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of CD44 in cancer chemoresistance: A concise review
- (2021) Zohreh Yaghobi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy
- (2021) Behzad Mansoori et al. LIFE SCIENCES
- Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology
- (2021) Marwa M. Hamed et al. LIFE SCIENCES
- Assessing the effect of human mesenchymal stem cell-derived conditioned media on human cancer cell lines: A systematic review
- (2021) A. Thirumal Raj et al. TISSUE & CELL
- miR‑497 inhibits proliferation and invasion in triple‑negative breast cancer cells via YAP1
- (2021) Yuan Li et al. Oncology Letters
- KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition
- (2021) Wei Jian et al. Gland Surgery
- MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer
- (2020) Jingwei Zhang et al. Cancer Biomarkers
- LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR‐200c‐3p to upregulate ANLN
- (2020) Min Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Protective effect of hsa‐miR ‐570‐3p targeting CD274 on triple negative breast cancer by blocking PI3K / AKT / mTOR signaling pathway
- (2020) Li‐Li Wang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- (-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells
- (2020) Fu Peng et al. Frontiers in Pharmacology
- LncRNA GATA3‐AS1 facilitates tumour progression and immune escape in triple‐negative breast cancer through destabilization of GATA3 but stabilization of PD‐L1
- (2020) Ming Zhang et al. CELL PROLIFERATION
- Endoplasmic reticulum stress‐induced exosomal miR‐27a‐3p promotes immune escape in breast cancer via regulating PD‐L1 expression in macrophages
- (2020) Xiaoli Yao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population
- (2020) Faezeh Vakhshiteh et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway
- (2020) Narges Dastmalchi et al. LIFE SCIENCES
- A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
- (2020) Alexis Forterre et al. Cancers
- Targeting hydrogen sulphide signaling in breast cancer
- (2020) Rana Ahmed Youness et al. Journal of Advanced Research
- T‐Cell‐Mimicking Nanoparticles for Cancer Immunotherapy
- (2020) Mikyung Kang et al. ADVANCED MATERIALS
- Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Breast Cancer Effect via miR-200c-PDE7B/PD-L1-AKT/MAPK Axis
- (2020) Yue Yang et al. Evidence-based Complementary and Alternative Medicine
- Cross-talk between myeloid-derived suppressor cells and Mucin1 in breast cancer vaccination: On the verge of a breakthrough
- (2020) Mahdi Abdoli Shadbad et al. LIFE SCIENCES
- Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers
- (2020) Danielle M. Valcourt et al. Molecular Therapy-Nucleic Acids
- Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
- (2020) Parisa Lotfinejad et al. Diagnostics
- LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production
- (2020) Heba Nafea et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Biomimetic nanoarchitecturing: A disguised attack on cancer cells
- (2020) Adrija Jha et al. JOURNAL OF CONTROLLED RELEASE
- siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468)
- (2020) Fatemeh Vahidian et al. MOLECULAR BIOLOGY REPORTS
- Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Karan Mediratta et al. Cancers
- MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1
- (2020) Shirin Azarbarzin et al. LIFE SCIENCES
- Suppressive effect of exogenous miR‐16 and miR‐34a on tumorigenesis of breast cancer cells
- (2019) Mehdi Haghi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- HOXC13‐AS promotes breast cancer cell growth through regulating miR‐497‐5p/PTEN axis
- (2019) Xiaowei Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors
- (2019) Christopher Fitzpatrick et al. Cell Death & Disease
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1
- (2019) Chengpeng Zhao et al. Breast Cancer
- T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
- (2019) Yutong Han et al. Advanced Science
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network
- (2019) Zijian Liu et al. Frontiers in Genetics
- LINC00096 Promotes the Proliferation and Invasion by Sponging miR-383-5p and Regulating RBM3 Expression in Triple-Negative Breast Cancer
- (2019) Yanyan Tian et al. OncoTargets and Therapy
- Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation
- (2019) Kaiyu Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer
- (2018) Jianling Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2
- (2018) Hua Zhong et al. Cancer Biomarkers
- Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery
- (2018) Jonathan O. Martinez et al. Theranostics
- Reversal of Triple-negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immune-Suppression
- (2018) Thomas J. Rogers et al. MOLECULAR CANCER RESEARCH
- MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase�1 in breast cancer cells
- (2018) Dan Xie et al. ONCOLOGY REPORTS
- Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma
- (2018) Xi Cao et al. Acta Pharmaceutica Sinica B
- PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
- (2017) Xiaojia Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
- (2017) Zhan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA‑193a‑3p inhibits cell proliferation in prostate cancer by targeting cyclin D1
- (2017) Yunfu Liu et al. Oncology Letters
- MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility
- (2017) Dengfeng Li et al. RSC Advances
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway
- (2016) Wentao Si et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer
- (2016) Yilin Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
- (2015) Yao-Yin Chang et al. Molecular Cancer
- miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ
- (2015) Xiao-Fei Zhang et al. Oncotarget
- SYRCLE’s risk of bias tool for animal studies
- (2014) Carlijn R Hooijmans et al. BMC Medical Research Methodology
- miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
- (2014) Ufuk Berber et al. Journal of Breast Cancer
- miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1
- (2014) Bao-ping Chang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells
- (2014) YI REN et al. Molecular Medicine Reports
- MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer
- (2014) QIFENG LUO et al. ONCOLOGY REPORTS
- Degradable Hyaluronic Acid/Protamine Sulfate Interpolyelectrolyte Complexes as miRNA-Delivery Nanocapsules for Triple-Negative Breast Cancer Therapy
- (2014) Shihua Wang et al. Advanced Healthcare Materials
- Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
- (2012) F. Penault-Llorca et al. ANNALS OF ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now